PATENT CLAIM ANALYSIS

Application Number: 16263512
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["546", "187000"]

Abstract:
This present disclosure is directed to compounds of formula (I): where R 1a , R 3 , Y, and Z are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A 4  hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions including the compounds described herein and methods of preparing the compounds described herein are also provided.

Claim (Index 4):
A compound of  claim 1  wherein R 3  is \u2014O\u2014 and Z is

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.45161
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15837515', '14313672', '11644244', '14849810', '15704199']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991101834793198
- 35 USC 102 Novelty (BERT): 0.5632094735020636
- Combined Prediction Score: 0.7755201124815941
- Mean Citation Score: 384.863876
- Max Citation Score: 466.39145
- Similarity Product: 322.19770219337346

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test